Hennion & Walsh Asset Management »

Immunitybio shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $755k 307k 2.46
2025-06-30 $477k 181k 2.64

More positions owned by Hennion & Walsh Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Wisdomtree Tr Dynamic Intl Eqt (DDWM)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Proshares Tr S&p 500 High Inc (ISPY)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Investment Grade (IGEB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)
Ishares Tr Pfd And Incm Sec (PFF)
Pimco Municipal Income Fund II (PML)
Alphabet Cap Stk Cl A (GOOGL)
Nuveen Muni Value Fund (NUV)

View all positions for Hennion & Walsh Asset Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
Jane Street
State Street Corporation
Geode Capital Management
Heights Capital Management
Woodline Partners
Susquehanna International
AlphaCore Capital
Morgan Stanley
Two Sigma Investments
Tang Capital Management
Charles Schwab Investment Management
Citadel Advisors
Northern Trust

View all funds holding Immunitybio